Secondary and tertiary structure changes of reconstituted P-glycoprotein.

被引:0
|
作者
Sonveaux, N
Shapiro, AB
Goormaghtigh, E
Ling, V
Ruysschaert, JM
机构
[1] FREE UNIV BRUSSELS, CHIM PHYS MACROMOL INTERFACES LAB, B-1050 BRUSSELS, BELGIUM
[2] BRITISH COLUMBIA CANC RES CTR, VANCOUVER, BC V5Z 1L3, CANADA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:MP322 / MP322
页数:1
相关论文
共 50 条
  • [1] Ligand-mediated structure changes of reconstituted P-glycoprotein.
    Sonveaux, N
    Shapiro, AB
    Vigano, C
    Ruysschaert, JM
    BIOPHYSICAL JOURNAL, 1999, 76 (01) : A102 - A102
  • [2] Secondary and tertiary structure changes of reconstituted P-glycoprotein - A Fourier transform attenuated total reflection infrared spectroscopy analysis
    Sonveaux, N
    Shapiro, AB
    Goormaghtigh, E
    Ling, V
    Ruysschaert, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) : 24617 - 24624
  • [3] Structure and mechanism of the human multidrug resistance P-glycoprotein.
    Clarke, DM
    Loo, TW
    FASEB JOURNAL, 1999, 13 (07): : A1521 - A1521
  • [4] Ligand-mediated tertiary structure changes of reconstituted P-glycoprotein: A tryptophan fluorescence quenching analysis
    Lab. Chim. Phys. Macromolec. I., Université Libre de Bruxelles, B-1050 Brussels, Belgium
    不详
    不详
    J Biol Chem, 25 (17649-17654):
  • [5] Ligand-mediated tertiary structure changes of reconstituted P-glycoprotein - A tryptophan fluorescence quenching analysis
    Sonveaux, N
    Vigano, C
    Shapiro, AB
    Ling, V
    Ruysschaert, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) : 17649 - 17654
  • [6] Secondary and tertiary structure changes of reconstituted LmrA during its catalytic cycle
    Vigano, C
    Margolles, A
    Konings, W
    van Veen, H
    Ruysschaert, JM
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 34A - 34A
  • [7] Structure-activity relationships of transmembrane inhibitors of P-glycoprotein.
    Tarasova, N
    Seth, R
    Michejda, CJ
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6072S - 6072S
  • [8] Lack of dextromethorphan interaction with P-glycoprotein.
    Kanaan, M
    Daali, Y
    Dayer, P
    Desmeules, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P10 - P10
  • [9] Antimalarial drugs are not substrates of human P-glycoprotein.
    Pauli-Magnus, C
    Lacayo, CI
    Kroetz, DL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P76 - P76
  • [10] Bosutinib is a Substrate of the ABC Efflux Transporter P-Glycoprotein.
    Perini, Pietro
    Redaelli, Sara
    Piazza, Rocco
    Viltadi, Michela
    Boschelli, Frank
    Gambacorti, Carlo
    BLOOD, 2009, 114 (22) : 1448 - 1449